NCCR Unveils Six New Public Service TV Announcements

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 4 No 3
Volume 4
Issue 3

WASHINGTON--The National Coalition for Cancer Research (NCCR), a Washington coalition of more than 20 cancer-related organizations founded in 1986, unveiled its new series of six 30-second television public service announcements at a

WASHINGTON--The National Coalition for Cancer Research (NCCR),a Washington coalition of more than 20 cancer-related organizationsfounded in 1986, unveiled its new series of six 30-second televisionpublic service announcements at a Capitol Hill ceremony. The campaignalso includes airport dioramas that repeat the TV messages.

Speaking about the budget process in which the 104th Congressis currently engaged, Rep. John Porter (R-Ill) reassured the Coalition:"Everybody agrees that downsizing is necessary, but cancerresearch is one place where we definitely do not want to cut."

Rep. Porter, chairman of the House Appropriations Subcommitteeon Labor, Health and Human Services, and Education and RelatedAgencies, pointed out in his talk that biomedical research isimportant not only for its role in finding ways to prevent andcure cancer, but also for the overall economy, since such researchprovides the country with "thousands of high-tech jobs."

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Taletrectinib showed improved efficacy in patients with ROS1-positive non–small cell lung cancer who were treatment-naïve.
“It’s a drug that I’m very comfortable with, and it is a drug I’ll likely use primarily in the first-line setting,” stated Jorge Nieva, MD, on taletrectinib in non–small cell lung cancer.
4 experts in this video
4 experts in this video
Those being treated for peritoneal carcinomatosis may not have to experience the complication rates or prolonged recovery associated with surgical options.
For patients with peritoneal carcinomatosis, integrating PIPAC into a treatment regimen does not interrupt their systemic therapy.